M. Ibrahim-Kosta

发表

Minor allele of the factor V K858R variant protects from venous thrombosis only in non-carriers of factor V Leiden mutation

D. Trégouët, M. Germain, P. Amouyel, 2019, Scientific Reports.

Elevated plasma Complement Factor H Regulating Protein 5 is associated with venous thromboembolism and COVID-19 severity

T. Renné, D. Tregouet, J. Odeberg, 2022, medRxiv.

A Genome Wide Association Study on plasma FV levels identified PLXDC2 as a new modifier of the coagulation process

D. Trégouët, P. Morange, P. Eriksson, 2019, Journal of thrombosis and haemostasis : JTH.

Laboratory Techniques Used to Diagnose Constitutional Platelet Dysfunction

M. Alessi, M. Ibrahim-Kosta, N. Hézard, 2020, Hämostaseologie.

Clinical validation of immunoassay HemosIL® AcuStar HIT-IgG (PF4-H) in the diagnosis of Heparin-induced thrombocytopenia

A. Loundou, P. Morange, L. Camoin-Jau, 2021, Journal of Thrombosis and Thrombolysis.

High prevalence of mutations in perilipin 1 in patients with precocious acute coronary syndrome.

A. Loundou, P. Morange, A. Blanchard, 2019, Atherosclerosis.

Ethnicity and Haemostasis: Challenge in the genomics era

P. Morange, M. Ibrahim-Kosta, 2020, Journal of thrombosis and haemostasis : JTH.

ABO blood group, glycosyltransferase activity and risk of venous thromboembolism.

D. Trégouët, P. Morange, J. Chiaroni, 2020, Thrombosis research.

Single-cell analysis of megakaryopoiesis in peripheral CD34+ cells: insights into ETV6-related thrombocytopenia

M. Poggi, D. Bastelica, M. Alessi, 2022, bioRxiv.

Screening platelet function in blood donors

M. Alessi, C. Falaise, J. Chiaroni, 2022, Transfusion.

An artificial neural network approach integrating plasma proteomics and genetic data identifies PLXNA4 as a new susceptibility locus for pulmonary embolism

D. Trégouët, J. Odeberg, P. Morange, 2020, Scientific Reports.

Bayesian network analysis of plasma microRNA sequencing data in patients with venous thrombosis

D. Trégouët, C. Perret, P. Morange, 2020, European heart journal supplements : journal of the European Society of Cardiology.

Association of ABO haplotypes with the risk of venous thrombosis: impact on disease risks estimation.

Andrew D. Johnson, D. Chasman, D. Trégouët, 2020, Blood.

Association of ABO blood groups with venous thrombosis recurrence in middle-aged patients: insights from a weighted Cox analysis dedicated to ambispective design

H. Jacqmin-Gadda, D. Trégouët, P. Morange, 2023, BMC Medical Research Methodology.

Minor allele of the factor V K858R variant protects from venous thrombosis only in non-carriers of factor V Leiden mutation

D. Trégouët, M. Germain, P. Amouyel, 2019, Scientific Reports.

Explainable Artificial Neural Network for Recurrent Venous Thromboembolism Based on Plasma Proteomics

Misbah Razzaq, Louisa Goumidi, Maria-Jesus Iglesias, 2021, CMSB.

Modelling of time-to-events in an ambispective study: illustration with the analysis of ABO blood groups on venous thrombosis recurrence

H. Jacqmin-Gadda, D. Trégouët, P. Morange, 2021, medRxiv.

Severe thrombophilia in a factor V‐deficient patient homozygous for the Ala2086Asp mutation (FV Besançon)

P. Morange, K. Wichapong, M. Poggi, 2021, Journal of thrombosis and haemostasis : JTH.

Elevated plasma complement factor H related 5 protein is associated with venous thromboembolism

T. Renné, D. Trégouët, F. Edfors, 2023, Nature communications.

Use of Sysmex XN‐10 red blood cell parameters for screening of hereditary red blood cell diseases and iron deficiency anaemia

I. Arnoux, M. Loosveld, A. L. Le Floch, 2020, International journal of laboratory hematology.